论文信息 - Apo A-I promoter polymorphism influences basal HDL-cholesterol and its response to pravastatin therapy. - 字舞流文

Apo A-I promoter polymorphism influences basal HDL-cholesterol and its response to pravastatin therapy.

R. Peña | C. Lahoz | X. Pintó | E. Subirats | J. Mostaza | M. Taboada | J. Jiménez | A. López-Pastor